Eleusis' lead candidate is ELE-101 – a patented IV formulation of psilocin, the active metabolite of magic mushroom compound psilocybin – which is in preparation for first-in-human testing.

Larnaka 2030 welcomes the junior team of the Paneleucinian Athletic Basketball Club. The athletes and their delegation, as well as colleagues from the team of Eleusis 2023, will spend four days in the ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.